Investigating how amyloid proteins interact and affect brain cells in Alzheimer's disease
Heterotypic amyloid interactions as modulators of selective cellular vulnerability
This study is looking at how certain proteins related to Alzheimer's disease clump together in the brain and how they interact with other proteins, which could help us understand the disease better and find new ways to treat it.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Flanders Interuniv Inst Biotechnology NIH-funded |
| Lab location | 1 site (Gent, Belgium) |
| Project ID | NIH-11099843 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of amyloid aggregates, which are key features of Alzheimer's disease, and how they interact with other proteins in the brain. By using advanced proteomic techniques, the study aims to identify the specific conditions that lead to the aggregation of amyloid beta and tau proteins, which are implicated in the disease. The researchers will systematically explore the interactions between these proteins and others to uncover the mechanisms behind their aggregation and the resulting cellular effects. This could provide insights into the initiation of Alzheimer's disease and potential therapeutic targets.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk of developing it due to genetic or other factors.
Not a fit: Patients with other forms of dementia or cognitive impairment unrelated to amyloid aggregation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing or treating Alzheimer's disease by targeting the mechanisms of amyloid aggregation.
How similar studies have performed: Previous research has shown promising results in understanding amyloid interactions, but this approach aims to provide novel insights into the specific mechanisms involved.
Where this research is happening
Gent, Belgium
- Flanders Interuniv Inst Biotechnology — Gent, Belgium (Active)
Researchers
- Principal investigator: Schymkowitz, Joost — Flanders Interuniv Inst Biotechnology
- Study coordinator: Schymkowitz, Joost
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.